Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102321040A details a low-cost resolution method for Linezolid intermediates using chiral acids, offering significant supply chain advantages for API manufacturers.
Advanced one-step resolution technology for high-purity Lacosamide intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for chiral pharmaceutical compounds.
Patent CN107778234A enables high-purity neuromuscular blocker synthesis. This process reduces cost and improves supply chain reliability for global pharmaceutical intermediates.
Novel chiral resolution method ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical intermediates manufacturing with optimized resolving agent recovery.
Patent CN104496806B reveals high-yield synthesis for chiral selectors. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced synthesis of 3-benzazepines via novel cyclization and reduction routes. Offers cost reduction in API manufacturing and scalable production for CNS disorder treatments.
Patent CN112979701A details a novel nickel-catalyzed resolution for L-glufosinate-ammonium. Achieve >95% yield and ee value with significant cost reduction in agrochemical manufacturing.
Patent CN113242854B reveals novel chiral resolution for S-IOBA. Enhances supply chain reliability and reduces manufacturing costs for agrochemical intermediates significantly.
Patent CN109232220B details a novel chiral resolution method offering high purity and scalable production for pharmaceutical intermediate supply chains.
Patent CN111440121B reveals a high-efficiency chiral resolution method for Tetrandrine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced resolution technology for Edoxaban precursor ensuring >99% ee. Optimized for cost-effective API manufacturing and reliable supply chain continuity.
Novel base-catalyzed racemization of larotrectinib intermediate enables recycling of S-isomer, reducing costs and waste for API manufacturing.
Patent CN102249998A reveals a high-yield synthesis route for Cisatracurium Besylate, offering superior purity and cost-effective manufacturing for pharmaceutical supply chains.
Novel enzymatic route for Finerenone intermediates reduces heavy metal risk and cost significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking green chemistry.
Patent CN108586517A details a cost-effective 4-AA synthesis route offering supply chain stability and high purity for global pharmaceutical manufacturing partners.
Discover the novel synthesis of 4-AA antibiotic intermediate via patent CN108586517A. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Patent CN115850115B reveals high-purity Ruxolitinib intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Advanced purification process for tenofovir prodrug ensuring high purity. Cost-effective supply chain solutions for pharmaceutical intermediates. Reliable manufacturing partner for global pharmaceutical companies seeking scalable synthesis routes.
Novel chiral resolution method enhances purity and yield for pharmaceutical intermediates. Optimized route ensures cost reduction and supply chain reliability for global buyers.
Patent CN118086121A reveals efficient biocatalytic route for R-Metalaxyl intermediate. Enhances purity and supply chain stability for global agrochemical manufacturers.